NetworkNewsBreaks

TuesdayFeb 13, 2024 2:39 pm

NetworkNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Names MarineMax Executive to Board

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, announced that Anthony E. Cassella Jr., executive vice president finance and chief accounting officer at MarineMax Inc. (NYSE: HZO) has been appointed to its board of directors; Cassella will serve as an independent director. According to the announcement, the appointment reflects VMAR’s leading role in marine technology innovation and underscores its commitment to strong corporate governance; the company noted that the veteran’s background and industry knowledge “will bring incredible value to the next chapter of Vision Marine's mission to become the leading provider…

Continue Reading

TuesdayFeb 13, 2024 2:23 pm

NetworkNewsBreaks – Optec International Inc. (OTC: OPTI) Focus of Judgment, RB Capital Provides Shareholder Update

Optec International (OTC: OPTI) is the focus of a judgment filed by California-based RB Capital Partners Inc., a private investment fund. A recent announcement noted that RB Capital was clarifying the judgment and releasing a shareholder update. According to the announcement, RB Capital observed that it was the largest investor and legitimate shareholder of OPTEC and was “forced to bring a shareholder derivative action against the company to secure our judgment, oust the failing [CEO] Roger Pawson and to try to preserve the assets of the company.” RB Capital filed the lawsuit, noting that Pawson used the company for self-dealing…

Continue Reading

TuesdayFeb 13, 2024 2:20 pm

NetworkNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’

Renovaro (NASDAQ: RENB) today announced the completion of its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, marking a new era in healthcare innovation. According to the announcement, the two subsidiaries will be under the parent organization, which was renamed Renovaro Inc. “We believe this combination marks a significant milestone in the journey of personalized medicine,” said Renovaro’s CEO Mark Dybul, MD. “Together, we believe that we are poised to…

Continue Reading

TuesdayFeb 13, 2024 2:12 pm

NetworkNewsBreaks – GEMXX Corp. (GEMZ) Announces Groundbreaking Start for January Product Deliveries

GEMXX (OTC: GEMZ), a pioneering mine-to-market gold, gemstone and jewelry producer, today announced a stellar start to the year with impressive product deliveries worth $1,051,374 at retail for the month of January. According to the announcement, January’s deliveries mark an incredible 600% increase compared to the same period last year, highlighting GEMXX's strong growth trajectory and its effective business strategies. “Our January delivery results are a testament to the hard work and dedication of the GEMXX team,” said Jay Maull, CEO of GEMXX Corporation. “Our ability to achieve such significant deliveries is a clear indication of our competitive edge in…

Continue Reading

TuesdayFeb 13, 2024 2:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis, most recently having served as marketing and commercial excellence lead for cell and gene therapies for Central, Southern and Eastern Europe. “I am pleased to welcome Liat to Scinai,” said Amir Reichman, Scinai’s CEO. “Her pharmaceutical sales, marketing and leadership experience, in particular in…

Continue Reading

TuesdayFeb 13, 2024 1:55 pm

NetworkNewsBreaks – Lelantos Holdings Inc. (OTC: LNTO) Moves Forward on Eco Management Systems Acquisition, Appoints New Board Member

Lelantos Holdings (OTC: LNTO), a company with a focus on sustainable energy, is taking the first step in its acquisition of Eco Management Systems, a full-service commercial and residential solar contractor. According to the announcement, Lelantos executed a memorandum of understanding with Eco to acquire 50% of the company and is now finalizing formal binding agreements. Lelantos reports that acquiring Eco will allow the company to expand its operations as well as add a residential solar program to its offerings. The company is planning on finalizing the acquisition after the successful completion of key milestones that have been identified. Eco…

Continue Reading

TuesdayFeb 13, 2024 1:40 pm

NetworkNewsBreaks – ROTH MKM Provides D-Wave Quantum Inc. (NYSE: QBTS) Analyst Day Takeaways, Reiterates Buy Rating

ROTH MKM attended D-Wave Quantum Inc.’s (“D-Wave” or “QBTS”) annual analyst day recently held at the company’s research & development headquarters. Suji Desilva, CFA, Managing Director and Senior Research Analyst at ROTH MKM, published an update as part of the investment bank’s ongoing equity research coverage to provide investors with a summary of the visit. Excerpts of the report include the following: “We believe QBTS leads the industry with 70 commercial customers and has significant pipeline visibility with its 25+ proof-of-concepts underway.” “We were encouraged by multiple QBTS customer presentations that highlight deep and impactful adoption of quantum annealing (QA).”…

Continue Reading

TuesdayFeb 13, 2024 1:29 pm

NetworkNewsBreaks – WestPark Capital Reiterates Buy Rating on D-Wave Quantum Inc. (NYSE: QBTS), Recaps Analyst Day Visit

WestPark Capital recently published its recap of the recent analyst day event hosted by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services. Highlights of the visit included discussions by several customers about the benefits they are experiencing by using D-Wave’s solutions, anticipation for the launch of the company’s next-generation quantum processor, additional opportunities in government, and a growing number of use cases that have the potential to expand the size of the market opportunity for D-Wave to $100 billion by 2030. A key excerpt of the report reads,…

Continue Reading

TuesdayFeb 13, 2024 1:10 pm

NetworkNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 in the same period in 2023; a strong consolidated balance sheet with $37 million in cash and liquid investments; and a year-to-date FY 2024 gross margin increase of 46% from 38% during the same period in 2023. In addition, the company reported that its 1st Detect subsidiary reentered detection and nondetection testing with the U.S. Transportation Security Administration (“TSA”) for cargo…

Continue Reading

TuesdayFeb 13, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Engages Global CRO to Support NDA Submission for Approval of Tonmya(TM) for Fibromyalgia Management

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation of cyclobenzaprine hydrochloride, for the management of fibromyalgia. “We are excited by our most recent positive Phase 3 study results of Tonmya and look forward to Rho’s support in preparing our NDA,” said Seth Lederman,…

Continue Reading